Fahar Merchant
Chief Executive Officer at MEDICENNA THERAPEUTICS CORP.
Net worth: 7 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Rosemina Merchant | F | - |
Intelligene Expressions, Inc.
Medicenna Therapeutics, Inc.
 Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | 24 years |
| Jack Geltosky | M | 78 | 16 years | |
| Albert Beraldo | M | - |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | 8 years |
| Andrew L. Strong | M | 57 |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | 5 years |
| Karen Dawes | F | 72 | 5 years | |
| Delphine Davan | F | - | 1 years | |
| John Sampson | M | - | 3 years | |
| Eamonn Peters | M | - | 1 years | |
| David Hyman | M | - | - | |
| Evelyn Pau | M | - | 1 years | |
| Minh To | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Lars Ekman | M | 74 | 10 years | |
| Allison Hulme | M | 61 | - | |
| Chandrakant Panchal | M | 74 |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | 7 years |
| Leonard J. Cox | M | 52 | 2 years | |
| Elizabeth Williams | F | - | 7 years | |
| David Swetlow | M | - | 2 years | |
| Christopher Harrs | M | 63 |
University of Western Ontario
| 7 years |
| William Li | M | 61 | 2 years | |
| Bruce Levitt | M | - |
University of Western Ontario
| 4 years |
| Samuel R. Denmeade | M | - | - | |
| William Middleton | M | - |
University of Western Ontario
| 7 years |
| Geoffrey P. Cornish | M | - |
University of Western Ontario
| 7 years |
| Amit Sobti | M | 45 | 2 years | |
| Nishan de Silva | M | 51 | 2 years | |
| Jonathan Leff | M | 55 | 2 years | |
| William R. Rohn | M | 80 | 3 years | |
| Mario Charles Vachon | M | - |
University of Western Ontario
| 6 years |
| Jay G. Goldman | M | 61 |
University of Western Ontario
| 5 years |
| Steve Kearns | M | - |
University of Western Ontario
| 6 years |
| Paul Woods | M | - |
University of Western Ontario
| 4 years |
| Tang Tyrol | M | 61 |
University of Western Ontario
| 4 years |
| Karim Mawji | M | - |
University of Western Ontario
| 4 years |
| David Kenneth Vickerman | M | - |
University of Western Ontario
| 4 years |
| Michael G. Hamilton | M | - |
University of Western Ontario
| 4 years |
| Michael Kilbourne | M | - |
University of Western Ontario
| 4 years |
| Gadi Mayman | M | - |
University of Western Ontario
| 2 years |
| Henry Vehovec | M | - |
University of Western Ontario
| 2 years |
| Michael Forer | M | 58 |
University of Western Ontario
| 4 years |
| Michael Talmage | M | - |
University of Western Ontario
| 4 years |
| Kevin Shea | M | - |
University of Western Ontario
| 4 years |
| James Swanson | M | - |
University of Western Ontario
| 4 years |
| Bruce J. Gitelman | M | - |
University of Western Ontario
| 2 years |
| Michael R. Cooper | M | - |
University of Western Ontario
| 4 years |
| Rob Lyman Jackson | M | - |
University of Western Ontario
| 3 years |
| Jeff Dobson | M | - |
University of Western Ontario
| 3 years |
| Tony Somers | M | - |
University of Western Ontario
| 4 years |
| Bruce Traversy | M | 58 |
University of Western Ontario
| 4 years |
| William Beattie | M | 64 |
University of Western Ontario
| 3 years |
| Craig Smith | M | 62 |
University of Western Ontario
| 4 years |
| King Fung Cheung | M | 56 |
University of Western Ontario
| 4 years |
| Fiona Wilson | F | - |
University of Western Ontario
| 4 years |
| Harold Chataway | M | 63 |
University of Western Ontario
| 3 years |
| Norah Joyce | F | - |
University of Western Ontario
| 3 years |
| Timothy J. Counsell | M | 66 |
University of Western Ontario
| 3 years |
| Martin Lochran | M | - |
University of Western Ontario
| 4 years |
| Ian Aitken | M | - |
University of Western Ontario
| 4 years |
| Harry Taylor | M | - |
University of Western Ontario
| 2 years |
| Scott McLean | M | 62 |
University of Western Ontario
| 4 years |
| Paul Raymond Badeski | M | - |
University of Western Ontario
| 2 years |
| Peter J. Hodson | M | 59 |
University of Western Ontario
| 4 years |
| Donald James Rae | M | 63 |
University of Western Ontario
| 2 years |
| Louis de Jong | M | - |
University of Western Ontario
| 4 years |
| Kenneth Lapierre | M | 66 |
University of Western Ontario
| 4 years |
| Andrew Morris | M | - |
University of Western Ontario
| 4 years |
| Mark R. McQueen | M | - |
University of Western Ontario
| 4 years |
| Roger Brent Fulton | M | 62 |
University of Western Ontario
| 3 years |
| Richard Young | M | 60 |
University of Western Ontario
| 4 years |
| Melanie Mary Ann Blue | F | - |
University of Western Ontario
| 4 years |
| Tong Hoo Tsoi | M | 59 |
University of Western Ontario
| 4 years |
| Jeffrey David Newcommon | M | - |
University of Western Ontario
| 4 years |
| Perry Dellelce | M | - |
University of Western Ontario
| 4 years |
| Thomas Cannon | M | - |
University of Western Ontario
| 4 years |
| John Ross | M | 65 |
University of Western Ontario
| 2 years |
| James R. Swayze | M | 60 |
University of Western Ontario
| 4 years |
| Jeff Moody | M | - |
University of Western Ontario
| 4 years |
| David Tomljenovic | M | - |
University of Western Ontario
| 4 years |
| Peter Conrad Chin | M | - |
University of Western Ontario
| 2 years |
| Sing Yam Fu | M | 62 |
University of Western Ontario
| 4 years |
| Roger O. MacLeod | M | - |
University of Western Ontario
| 3 years |
| Alfred A. Jay | M | - |
University of Western Ontario
| 4 years |
| Kimberley Okell | F | - |
University of Western Ontario
| 4 years |
| Donald Hoy | M | 68 |
University of Western Ontario
| 4 years |
| Daniel Burns | M | 63 |
University of Western Ontario
| 4 years |
| Zoran Vukasinovic | M | - |
University of Western Ontario
| 4 years |
| Michael Berry | M | 58 |
University of Western Ontario
| 4 years |
| David Robert Driscoll | M | - |
University of Western Ontario
| 4 years |
| Robert J. Fuller | M | - |
University of Western Ontario
| 4 years |
| Gus Papageorgiou | M | - |
University of Western Ontario
| 5 years |
| Ian Fowler | M | 59 |
University of Western Ontario
| 4 years |
| Charles Taerk | M | - |
University of Western Ontario
| 4 years |
| Roy Thomas Graydon | M | 62 |
University of Western Ontario
| 2 years |
| Kathleen Dorey | F | - |
University of Western Ontario
| 4 years |
| Mark Usher | M | - |
University of Western Ontario
| 4 years |
| Colin Foster | M | 61 |
University of Western Ontario
| 2 years |
| Henry C. Eaton | M | - |
University of Western Ontario
| 2 years |
| Pierre J. Schuurmans | M | - |
University of Western Ontario
| 4 years |
| Jim J. Miller | M | 64 | 5 years | |
| Paul Baay | M | 61 |
University of Western Ontario
| 4 years |
| Matthew C. Wunder | M | - |
University of Western Ontario
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 100 | 100.00% |
| United Kingdom | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Fahar Merchant
- Personal Network
